NCT02244216View on ClinicalTrials.gov

Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

CompletedOBSERVATIONAL
Enrollment

2,914

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

June 30, 2000

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berotec® N 100 µg Metered-dose Inhaler

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY